Report overview
Viral vector vaccines combine many of the positive qualities of DNA vaccines with those of live attenuated vaccines.
This report aims to provide a comprehensive presentation of the global market for Viral Vector Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Vaccines. This report contains market size and forecasts of Viral Vector Vaccines in global, including the following market information:
Global Viral Vector Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Viral Vector Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Viral Vector Vaccines companies in 2022 (%)
The global Viral Vector Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Adenovirus Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Viral Vector Vaccines include Advanced Bioscience Laboratories, Boehringer Ingelheim, Brammer Bio, Creative Biogene, GE Healthcare, Pfizer and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Viral Vector Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vector Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Viral Vector Vaccines Market Segment Percentages, by Type, 2022 (%)
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Others
Global Viral Vector Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Viral Vector Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Viral Vector Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Viral Vector Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Vector Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Viral Vector Vaccines revenues share in global market, 2022 (%)
Key companies Viral Vector Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Viral Vector Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Advanced Bioscience Laboratories
Boehringer Ingelheim
Brammer Bio
Creative Biogene
GE Healthcare
Pfizer
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Viral Vector Vaccines, market overview.
Chapter 2: Global Viral Vector Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Viral Vector Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral Vector Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Viral Vector Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
